Lierac In-Store Event/Gilda's Club Initiative - October 23, 2009
NEW YORK, Oct. 19 /PRNewswire/ -- Lierac Paris Skincare announces Lierac in-store event to support Gilda's Club NYC. (Photo: http://www.newscom.com/cgi-bin/prnh/20091019/NY94591 ) WHO: 100,000 consumers will have the opportunity to visit Lierac Paris European Skincare Centers at 700 participating CVS/pharmacy and Longs Drugs. WHAT: On October 23, 2009, customers will be able to contribute to Gilda's Club of NYC with every Lierac purchase. For each product bought, Lierac will donate $1 from its sale to the foundation. Gilda's Club NYC provides free support to individuals living with cancer and their families. The organization has a unique philosophy that emphasizes interaction among its members, namely "community-building, collective wisdom, and shared experience." Gilda's Club also avoids discussing cancer using terms that carry a negative connotation. Instead, they seek to empower individuals through the use of their own "Gilda's Club language." WHEN: Friday, October 23rd, 2009 WHERE: 700 participating CVS/pharmacy and Longs Drugs stores. For locations, contact 1.877.5LIERAC or visit www.lierac-usa.com. About Lierac Paris Lierac Paris is manufactured and distributed by Ales Group, USA, a subsidiary of Ales Groupe, headquartered in Bezons, France. Founded by Dr. Cariel, a French physician specializing in corrective cosmetic medicine, Lierac Laboratories have been pioneers in skin repair and correction-oriented phyto-cosmetics since 1975. All Lierac Paris products are formulated to deliver effectiveness, safety and pleasure of use. Incorporating leading-edge technologies, Lierac Paris products derive their effectiveness from the field of phyto-therapy, using the most active resources of plants combined with the latest innovations in biotechnology. For more information or to find a local retailer, visit www.lierac-usa.com Twitter: @lieracskincare SOURCE Lierac Paris Jenna Muller, +1-212-707-6240, jmuller@alesgroup.com, or Anne-Cecile Blanchot, +1-212-707-6241, ablanchot@alesgroup.com
© Thomson Reuters 2009 All rights reserved




